Blastomycosis: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
* [[Fungus]]: Blastomyces dermatitidis | * [[Fungus]]: Blastomyces dermatitidis | ||
* Lives in moist soil, wooded areas | * Lives in moist soil, wooded areas | ||
* Spores airborne | ** Spores are airborne | ||
* North, Central and South America | * North, Central and South America | ||
* Southeast and Midwest US (Mississippi and Ohio River valleys) | ** Southeast and Midwest US (Mississippi and Ohio River valleys) | ||
* Reportable disease | *Causes a systemic pyogranulomatous infection | ||
* '''Reportable disease''' | |||
==Clinical Features== | ==Clinical Features== | ||
*Up to 50% of cases will be asymptomatic | |||
* Incubation period: 3-6 weeks | |||
* Flu like symptoms: [[Fever]], chills, cough, muscle aches, joint pain, [[chest pain]] | * Flu like symptoms: [[Fever]], chills, cough, muscle aches, joint pain, [[chest pain]] | ||
* | * Other systemic symptoms: Weight loss, night sweats, chills | ||
* Pulmonary: most common | * Pulmonary: most common | ||
** Acute or chronic pneumonia | ** Acute or chronic pneumonia | ||
| Line 33: | Line 33: | ||
* Keratoacanthoma | * Keratoacanthoma | ||
==Workup== | ==Diagnosis== | ||
===Workup=== | |||
* Fungal culture (Blood, sputum, bone marrow, liver or skin) : Broad based buds | * Fungal culture (Blood, sputum, bone marrow, liver or skin) : Broad based buds | ||
* Antigen test (Serum or urine) | * Antigen test (Serum or urine) | ||
| Line 57: | Line 58: | ||
==Disposition== | ==Disposition== | ||
* Subclinical disease: Observation and no treatment | * Subclinical disease: Observation and no treatment | ||
* Patients with | * Patients with immunosuppression or progressive pulmonary or extrapulmonary symptoms need treatment and often admission | ||
* Some may need ICU | * Some may need ICU | ||
| Line 66: | Line 67: | ||
* http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Blastomycosis.pdf | * http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Blastomycosis.pdf | ||
== | ==References== | ||
<references/> | <references/> | ||
[[Category:ID]] | [[Category:ID]] | ||
Revision as of 06:52, 18 August 2015
Background
- Fungus: Blastomyces dermatitidis
- Lives in moist soil, wooded areas
- Spores are airborne
- North, Central and South America
- Southeast and Midwest US (Mississippi and Ohio River valleys)
- Causes a systemic pyogranulomatous infection
- Reportable disease
Clinical Features
- Up to 50% of cases will be asymptomatic
- Incubation period: 3-6 weeks
- Flu like symptoms: Fever, chills, cough, muscle aches, joint pain, chest pain
- Other systemic symptoms: Weight loss, night sweats, chills
- Pulmonary: most common
- Acute or chronic pneumonia
- Diffuse pneumonitis, ARDS
- Skin:
- Verrucous lesion with irregular borders
- Microabscess (cold), subcutaneous nodules
- Ulcers that bleed easily and well-demarcated
- Bone: Osteomyelitis, chronic draining sinus, paravertebral abscess
- Genitourinary: Prostatitis, epididymo-orchitis
- CNS: Meningitis, epidural/intracranial abscess in immunocompromised
- Can involve breast, adrenal, thyroid, eye, lymph node, liver, spleen
Differential Diagnosis
- Pneumonia
- Malignancy
- Tuberculosis
- Histoplasmosis
- Pyoderma gangrenosum
- Keratoacanthoma
Diagnosis
Workup
- Fungal culture (Blood, sputum, bone marrow, liver or skin) : Broad based buds
- Antigen test (Serum or urine)
- Histopathology
- Serologic testing
- HIV testing
- CXR: Alveolar infiltrates +/- cavitation, mass lesions, miliary or reticulo- or fibronodular pattern, pleural effusions, upper lobe infiltrat
- Chest CT: Nodules, consolidation +/- cavitation, tree-in-bud opacities, pleural effusion, lack hilar adenopathy
- Xray of bone: Well-circumscribed osteolytic lesion
- Xray vertebrae: Lytic lesion in anterior vertebral body and destruction of disc space
- Bronchoscopy
Management
- ID consult
- Mild or moderate infections: Itraconazole (200mg TID x 3 days then once or twice daily x 6-12 months)
- Alternative: Fluconazole or ketoconozale (400-800mg/day)
- Azoles embryotoxic and teratogenic, avoid in pregnancy
- Severe infection: Amphotericin B (Lipid 3-5mg/kg IV daily or deoxycholate 0.7-1mg/kg IV daily)
- All immunocompromised patient should receive amphotericin B
- Lipid for all patients, except children
- If CNS involvement, lipid for all patients
Disposition
- Subclinical disease: Observation and no treatment
- Patients with immunosuppression or progressive pulmonary or extrapulmonary symptoms need treatment and often admission
- Some may need ICU